Duc-Minh Nguyen-Le

Duc-Minh Nguyen-Le

Auto-generated profile, based on publicly available information

Duc-Minh Nguyen-Le

Loma Linda University 1 Department of Oral and Maxillofacial Surgery, School of Dentistry Loma Linda, California

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 April 2025 in mSphere
Verified
Journal Article
Open access
Trinh Phan-CanhTrinh Phan-Canh
Trinh Phan-Canh
DNDuc-Minh Nguyen-Le
Duc-Minh Nguyen-Le
PLPhuc Loi Luu
Phuc Loi Luu
NKNarakorn Khunweeraphong
Narakorn Khunweeraphong
KKKarl Kuchler
Karl Kuchler
The pan-antifungal-resistant pathogen Candida auris has been causing high-mortality infection outbreaks in hospitals and healthcare settings. The prodrug 5-fluorocytosine (5FC) is one of four chemical entities, but its clinical use as an antifungal drug has been limited owing to pronounced resistance. However, antifungal combination therapy with 5FC appears as a promising strategy for treating C. auris infections. Here, we show that a C. auris clinical isolate can rapidly acquire genetic mutations to mount 5FC resistance after only one to two passages under drug selection. We exploit a new bioinformatics workflow to identify genetic polymorphisms from RNA-seq data. Strikingly, we identify several mutations in the FUR1 gene encoding the 5-fluorouracil convertase that normally generates the active drug. A single nonsense mutation truncates the enzyme at residue Q30*, leading to 5FC resistance due to inactive Fur1. Whole-genome sequencing analysis revealed that an indel mutation in FCY2 also contributes to 5FC resistance. Furthermore, at least one out of seven adapted strains acquired enhanced 5FC tolerance without mutations in the 5FC conversion pathway. Thus, we demonstrate that FUR1 mutations are critical drivers of 5FC resistance in C. auris . IMPORTANCE: Candida auris is a high-priority human fungal pathogen, causing infection outbreaks of high mortality in healthcare settings. Antifungal combination therapy with 5-fluorocytosine (5FC) is one of the emerging approaches in treatment. However, acquired 5FC resistance traits have been a matter of concern. 5FC is taken up by fungal cells via a cytosine permease and further metabolized by a cytosine deaminase to 5-fluorouracil (5FU). 5FU is then converted by the Fur1 uracil phosphoribosyltransferase into a toxic antimetabolite that disrupts fungal RNA and DNA syntheses. Mutations in these proteins are commonly associated with 5FC resistance in fungal species. Here, we show that C. auris can rapidly develop resistance under 5FC selective stress owing to mutational inactivation of Fur1 function. Moreover, other mechanisms that bypass mutations in the 5FC conversion pathway may also contribute to 5FC resistance traits. Finally, we have developed a tailored bioinformatics workflow that facilitates the identification of polymorphisms associated with 5FC resistance in clinical isolates.

2 November 2026
Verified
Other
Open access
AN LUONGAN LUONG
AN LUONG
MDMinh Phuong Dong
Minh Phuong Dong
DNDuc-Minh Nguyen-Le
Duc-Minh Nguyen-Le
MAMichele Arambula
Michele Arambula
KAKesava Asam
Kesava Asam
CVChi Tonglien Viet
Chi Tonglien Viet
Oral squamous cell carcinoma (OSCC) is associated with poor survival due to challenges with timely diagnosis and surveillance. Noninvasive biopsy methods, such as brush swab biopsy, have emerged as a promising approach with several clinical advantages over surgical biopsies, which may help overcome challenges in diagnosis, prognostication, and surveillance. We aimed to evaluate a noninvasive brush swab method for nucleic acid collection suitable for RNA sequencing in patients with OSCC. Brush swabs were collected from tumor sites before surgery, followed by corresponding fresh-frozen tissue samples from the same sites during surgical resection. Thirty-nine patients were enrolled [median age, 65 years (IQR, 55–73)]. As expected, tissue samples yielded higher RNA concentration and integrity than swabs [456.3 ng/μL (IQR, 291.3–651.3) vs. 73.2 ng/μL (IQR, 34.9–106.3); DV200, 91.6% (IQR, 85.9–93) vs. 82% (IQR, 77.3–87.8); both P < 0.0001]. Despite lower RNA quality, swab samples showed a high sequencing mapping rate after bacterial rRNA depletion [84.3% (IQR, 67.3–91.1)]. Gene expression profiles were strongly correlated between matched tissues and swabs (r = 0.969; 95% confidence interval, 0.967–0.969; P < 2.2e−16). We developed and validated a protocol for total transcriptomic profiling of brush swab samples and demonstrated excellent concordance with paired tissue samples in patients with OSCC. These findings support the use of brush swabs as a noninvasive alternative for biomarker discovery, with potential applications in OSCC diagnosis and prognostication. Prevention Relevance:Brush swab sampling is a simple, minimally invasive method to assess molecular changes in oral cancer, yielding results comparable with tissue samples. Its low burden and repeatability support early detection, monitoring, and risk assessment. Its practicality in dental and community settings enables broader access to screening and preventive care.

2 November 2026
Verified
Other
Open access
AN LUONGAN LUONG
AN LUONG
MDMinh Phuong Dong
Minh Phuong Dong
DNDuc-Minh Nguyen-Le
Duc-Minh Nguyen-Le
MAMichele Arambula
Michele Arambula
KAKesava Asam
Kesava Asam
CVChi Tonglien Viet
Chi Tonglien Viet
Supplementary Figure S1- shows the RNA-seq data processing pipeline, including quality control, read trimming, alignment, post-alignment QC, and downstream quantification and reporting steps.

23 March 2026 in Human Molecular Genetics
Verified
Journal Article
Closed access
NHNguyen Cong Hoang
Nguyen Cong Hoang
DNDuc-Minh Nguyen-Le
Duc-Minh Nguyen-Le
HTHuyen-Trang Thi Tran
Huyen-Trang Thi Tran
TNThanh Tra Nguyen
Thanh Tra Nguyen
MNManh Hung Nguyen
Manh Hung Nguyen
PLPhuc Loi Luu
Phuc Loi Luu
Congenital hearing loss (HL) in the Vietnamese population remains understudied despite its genetic diversity, limiting our understanding of its genetic etiology and hindering the development of effective, population-specific diagnostic strategies. In this descriptive cross-sectional whole-exome sequencing study, we enrolled 150 children with congenital non-syndromic HL (NSHL) from hospitals and hearing centers across Northern, Central, and Southern Vietnam to describe the genetic landscape of HL and provide new insights into rare and HL-associated variants. Clinical variant annotation was performed for 1589 deafness-associated genes, focusing on pathogenic, likely pathogenic, and variants of uncertain significance. Genetic factors strongly associated with NSHL accounted for 7.33% (11 of 150) of moderate-to-profound HL cases, involving both autosomal dominant and autosomal recessive inheritance patterns. Four variants across three genes were identified, namely GJB2:c.235del (p.L79CfsTer3), GJB2:c.109G > A (p.V37I), COCH:c.538C > T (p.R180Ter), and MYO6:c.2751dup (p.Q918TfsTer24). Two of these variants demonstrated a trend toward disease enrichment within the cohort, with the highest minor allele frequency (MAF) observed in GJB2:c.109G > A at 11%, followed by MYO6:c.2751dup at 2%. Although GJB2:c.235del showed a relatively high MAF of 1.3%, the observed minor alleles did not differ significantly from those in the East Asian and KHV control populations. These findings reveal distinct clinical and molecular profiles of congenital HL, providing essential knowledge for the development of targeted screening and diagnostic strategies tailored to the Vietnamese pediatric population.

2 November 2026
Verified
Other
Open access
AN LUONGAN LUONG
AN LUONG
MDMinh Phuong Dong
Minh Phuong Dong
DNDuc-Minh Nguyen-Le
Duc-Minh Nguyen-Le
MAMichele Arambula
Michele Arambula
KAKesava Asam
Kesava Asam
CVChi Tonglien Viet
Chi Tonglien Viet
Supplementary Table S1 summarizes RNA quality metrics for swab and tissue samples, sequencing quality statistics for swab samples (with and without bacterial rRNA depletion) as well as tissue samples, and gene detection profiles for paired samples, including counts of shared and tissue-specific genes across both global and OSCC-associated gene sets.

2 November 2026
Verified
Other
Open access
AN LUONGAN LUONG
AN LUONG
MDMinh Phuong Dong
Minh Phuong Dong
DNDuc-Minh Nguyen-Le
Duc-Minh Nguyen-Le
MAMichele Arambula
Michele Arambula
KAKesava Asam
Kesava Asam
CVChi Tonglien Viet
Chi Tonglien Viet
Supplementary Figure S4 - Gene expression concordance and overlap of HNSCC-Associated genes between swab and tissue samples. (A) Heatmap illustrates the Pearson correlation coefficients r of gene expression level, normalized to Transcript Per Million (TPM), across all samples, with color intensity representing the strength of correlation. (B) A Venn diagram shows the overlap of genes, with significant genes of HNSCC cancer in oncodb database, identified from both swab (n=39)(yellow) and tissue (n=39)(blue) samples.